Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus Co-infection: Indian Perspectives. (4th October 2022)

• Record Type: Journal Article
• Authors: Venkatesh, U.; Ish, Pranav; Kumari, Shilpi; Gupta, Nitesh; Sharma, Akash
• Is Part Of: Disaster medicine and public health preparedness. Volume 16:Number 5(2022)
• Page Start: 1769
• Page End: 1771
• Publication Date: 2022-10-04
• Subjects: Disaster medicine -- Periodicals; Emergency management -- Planning -- Periodicals; Public health -- Periodicals; 363.34
• DOI: 10.1017/dmp.2021.254
• Languages: English
• ISSNs: 1935-7893

Abstract

Abstract: Severe acute respiratory syndrome Coronavirus 2 (SARS CoV-2) and Dengue virus (DENV) Coinfection can be a pertinent issue in a country like India, where Dengue is endemic, and Coronavirus disease 19 (COVID-19) is also reported from all states of the country. The coinfection of these viruses has already been reported in different dengue‐endemic countries like Singapore, Thailand, and Bangladesh. The outcome and the dynamics of each of the diseases may be altered in the presence of coinfection. We highlighted the critical characteristic similarities and differences between COVID-19 and Dengue infection & the specific point, which may challenge diagnosing and managing these coinfections. COVID-19 and Dengue coinfection can be deadly in combination with an atypical presentation, providing diagnostic and therapeutic challenges. A high index of suspicion, early recognition of symptoms, and warning signs are vital to prevent double jeopardy.